Litcius/Paper detail

Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice

Huiwen Wang, Jian Zhang, Xiaoxun Zhang, Nan Zhao, Zongtao Zhou, Lijian Tao, Lei Fu, Shifang Peng, Jin Chai

2022Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease19 citationsDOI

Topics & Concepts

CholestasisInternal medicineFibrosisEndocrinologySMADUrsodeoxycholic acidObeticholic acidBile acidHepatic fibrosisInflammationMedicineAlkaline phosphataseChemistryTransforming growth factorBiochemistryEnzymeReceptorAgonistDrug Transport and Resistance MechanismsPediatric Hepatobiliary Diseases and TreatmentsLiver Disease Diagnosis and Treatment
Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice | Litcius